Skip to main content

Table 9 Results of diagnostic value of imaging

From: Imaging in assessing hepatic and peritoneal metastases of gastric cancer: a systematic review

Imaging modality

Sen (95%CI)

Spe (95%CI)

DOR (95%CI)

Liver metastasis

US

0.54

(0.34-0.73)

0.98

(0.90-0.99)

50.25

(13.48-187.32)

 

CT

0.74

(0.59-0.85)

0.99

(0.97-1.00)

251.14

(83.53-755.07)

 

PET

0.70

(0.36-0.90)

0.96

(0.81-0.99)

56.46

(8.47-376.23)

Peritoneal metastasis

US

0.09

(0.03-0.21)

0.99

(0.96-1.00)

10.63

(1.54-73.36)

 

EUS

0.34

(0.10-0.69)

0.96

(0.87-0.99)

13.07

(6.42-26.62)

 

CT

0.33

(0.16-0.56)

0.99

(0.98-1.00)

66.18

(27.28-160.53)

 

PET

0.28

(0.17-0.44)

0.97

(0.83-1.00)

12.49

(2.22-70.10)

  1. Sen: sensitivity; Spe: Specificity; DOR: diagnostic odds ratio; CI: confidence interval.
  2. The results were combined using the metandi command (based on bivariate model) in stata software.